Home > Medical > Cervical cancer > News News All sections in Cervical Cancer » About Cervical Cancer » Cervical Cancer Vaccine » FAQs » Cervical Cancer News » Real-life Story Don’t delay your pap smear Does the idea of a pap smear make you cringe? Don’t let cost or squeamishness put you off – cervical cancer kills... One dose of HPV vaccine may prevent cervical cancer A single dose – rather than the recommended three – of a vaccine against the sexually transmitted disease HPV may be enough to ward off cervical cancer, researchers have found. SA to fund cervical cancer vaccines for girls South Africa will become the first African country to fund cervical cancer vaccines for schoolgirls as this is a killer disease. Quiz Cancer: are you at risk? » Ask CyberDoc » Quiz Am I eating to optimise my health? » Subscribe Newsletters » Medicines that changed history 10 famous breast cancer survivors HPV a cause of oropharyngeal cancer in US youth The sexually transmitted human papillomavirus may be behind the sharp rise in cases of throat and mouth cancers among young American adults. Doctors reluctant to recommend HPV vaccine Doctors' reluctance to recommend the human papillomavirus vaccine may be the reason why not enough teens are being vaccinated, according to US health officials. Avastin may boost survival in advanced cervical cancer: study Women on Avastin plus standard chemo live about 4 months longer on average. New guidelines may miss cancer in women New guidelines that recommend less stringent cervical cancer testing may result in a higher incidence of a particularly aggressive type of cervical cancer in young women, a new study suggests. Cervical cancer kills more than breast cancer A report says cervical cancer is alarmingly common among Southern African women and it affects roughly 1 in 36. Cervical cancer vaccinations in SA Cervical cancer is the second most common cancer in SA women, but fear not, because there's a vaccine available that might help. Roche's Avastin extends life in advanced cervical cancer Roche Holding AG's drug Avastin helped prolong the lives of women with advanced cervical cancer when added to chemotherapy in a late-stage clinical trial, likely paving the way to another major use for the multibillion-dollar medicine. load more articles advertisement From our sponsors Your retirement - a healthy mindset So many people, why so alone? You can still enjoy the sweet things in life Take the sugar test, it could save your life.